Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirena intrauterine system for heavy menstrual bleeding in women with and without uterine fibroids
2011-001461-40Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of avatrombopag in hypermenorrhea and Fibromyoma (LM) (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Menstrual blood loss. Started May 2011; status: terminated.
02
Drugs
avatrombopag
03
Conditions
hypermenorrheaFibromyoma (LM)
Beyond the preview
Go deeper on 2011-001461-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001461-40.